Inhibiting Autophagy Increases Epirubicin's Cytotoxicity in Breast Cancer Cells

Abstract

Chemotherapy, radiotherapy, and endocrinotherapy are documented to induce autophagy among breast cancer cells, but the role of autophagy in this disease has been attributed to be cytoprotective as well as tumor-suppressing. Thus we studied MDA-MB-231 and SK-BR-3 breast cancer cell lines treated with epirubicin (EPI) to assess autophagy and apoptosis. We found out that EPI induced apoptosis and autophagy in both cell lines, the lysosomal inhibitor bafilomycin A1 (BAF) inhibited cellular autophagy and enhanced EPI-triggered apoptosis perhaps due to inhibition of autolysosome formation, which then inhibited autophagic effects of engulfing and clearing damaged mitochondria. This inhibition increased mitochondrial cytochrome C release which augmented epirubicin-induced caspase-dependent apoptosis and cytotoxicity. Besides, the lysosomal neutralizing agent Ammonia Chloride (AC), and Atg7 knockdown by siRNA, could inhibit Epirubicin-triggered autophagy, enhance cytotoxicity, and increase caspase-9,-3 dependent apoptosis. Thus, autophagy plays a prosurvival role in EPI-treated MDA-MB-231 and SK-BR-3 cells, and autophagy inhibition can potentially reverse this effect and increase EPI's cytotoxicity.

This article is protected by copyright. All rights reserved.

from Cancer via ola Kala on Inoreader http://ift.tt/2bDQ8Lj
via IFTTT